Clinical Research Directory
Browse clinical research sites, groups, and studies.
Reperfusion Treatment in Acute Pulmonary Embolism
Sponsor: Sahlgrenska University Hospital
Summary
International guidelines recommend immediate reperfusion with systemic thrombolysis (ST) as first-line treatment in high-risk pulmonary embolism (PE). The therapy improves hemodynamics and overall survival but is also associated with a significant risk of severe bleeding. Catheter-directed intervention (CDI) is recommended as an alternative reperfusion therapy in high-risk PE when ST is contraindicated or has failed, as well as in patients who deteriorate or fail to improve during anticoagulation (AC) treatment. Despite lack of high-quality evidence and randomized studies between CDI and standard care, the use of CDI is spreading rapidly in high-risk PE and in less severe PE not fulfilling current treatment criteria.
Official title: Reperfusion Treatment in Acute Pulmonary Embolism: A Multicenter Observational Study in the Nordic Countries
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
220
Start Date
2025-04-01
Completion Date
2029-05-01
Last Updated
2026-01-21
Healthy Volunteers
No
Conditions
Interventions
Catheter directed intervention, any device
Catheter directed intervention for treatment of pulmonary embolism
Alteplase
Systemic thrombolysis
Locations (13)
Aarhus University Hospital
Aarhus, Denmark
Rigshospitalet
Copenhagen, Denmark
Odense University Hospital
Odense, Denmark
Sahlgrenska University Hospital
Gothenburg, Sweden
Linköping University Hospital
Linköping, Sweden
Sunderby Hospital
Luleå, Sweden
Skåne University Hospital
Lund, Sweden
Örebro University Hospital
Örebro, Sweden
Danderyd Hospital
Stockholm, Sweden
Karolinska University Hospital Huddinge
Stockholm, Sweden
Karolinska University Hospital Solna
Stockholm, Sweden
Södersjukhuset
Stockholm, Sweden
Uppsala University Hospital
Uppsala, Sweden